HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemoprevention of the naturally occurring carcinogen 1-hydroxyanthraquinone-induced carcinogenesis by the nonsteroidal anti-inflammatory drug indomethacin in rats.

Abstract
The chemopreventive effect of the nonsteroidal anti-inflammatory drug indomethacin (IMC) on 1-hydroxyanthraquinone (1-HA)-induced carcinogenesis was investigated in a total of 69 male ACI/N rats. Animals in Group 1 were fed the diet containing 1.5% 1-HA for 48 weeks. The rats in Group 2 were given the 1-HA diet together with 16 ppm IMC in the drinking water for 48 weeks. Group 3 was given IMC alone throughout the study. Group 4 was served as an untreated control. At the end of the study, the incidences of large bowel and forestomach tumors in Group 2 were significantly smaller than those in Group 1 (large bowel tumors: 0/14 rats, 0% in Group 2 versus 12/27 rats, 44% in Group 1, p < 0.002; forestomach tumors: 2/14 rats, 14% in Group 2 versus 14/27 rats, 52% in Group 1, p < 0.01). Also, the incidences of inflammatory changes including ulcerative colitis and melanosis coli in colonic mucosa of rats of given 1-HA together with IMC were significantly reduced compared with those in rats given 1-HA alone (ulcerative colitis: 2/14 rats, 14% in Group 2 versus 20/27 rats, 74% in Group 1, p < 0.004). Concurrent administration of IMC with 1-HA caused a significant decrease in the bromodeoxyuridine labeling index of the colonic mucosa. These results indicate that the nonsteroidal anti-inflammatory drug IMC inhibits 1-HA-induced carcinogenesis and that this effect in decreasing the cell proliferation.
AuthorsT Tanaka, M Suzui, T Kojima, K Okamoto, A Wang, H Mori
JournalCancer detection and prevention (Cancer Detect Prev) Vol. 19 Issue 5 Pg. 418-25 ( 1995) ISSN: 0361-090X [Print] England
PMID7585728 (Publication Type: Journal Article)
Chemical References
  • Anthraquinones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticarcinogenic Agents
  • Carcinogens
  • Ornithine Decarboxylase Inhibitors
  • 1-hydroxyanthraquinone
  • Indomethacin
Topics
  • Animals
  • Anthraquinones (toxicity)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Anticarcinogenic Agents (therapeutic use)
  • Carcinogens (toxicity)
  • Gastrointestinal Neoplasms (chemically induced, prevention & control)
  • Indomethacin (therapeutic use)
  • Male
  • Ornithine Decarboxylase Inhibitors
  • Rats
  • Rats, Inbred ACI

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: